Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2017

2017-08-30
Price :
Published : Aug-2017
No. of Pages : 144

Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2017” provides an overview of Influenza A Virus, H1N1 Subtype Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Influenza A Virus, H1N1 Subtype Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

University of Texas Health Science Center at Houston – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary University of Texas Health Science Center at Houston (UTHealth), a subsidiary of University of Texas System is an educational institution that provides research, education and patient care services. The university operates with schools of biomedical informatics, biomedical sciences, dentistry, medicine, nursing and public health. It offers clinical research education course that is conducted by clinical trial research professionals and examines the entire clinical trial process. The university's teaching hospitals include Memorial Hermann-Texas Medical Center, Children's Memorial Hermann Hospital and Harris Health Lyndon B. Johnson General Hospital. UTHealth is headquartered in Houston, Texas, the US. University of Texas Health Science Center at Houston - Pharmaceuticals & He......
$250

Tesaro Inc (TSRO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company's first commercial product is approved for use in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. The company distributes the product in the US principally through specialty distributors and specialty pharmacy channel. Its development portfolio includes novel cancer and supportive care product candidates in various development stages. Tesaro is headquartered in Waltham, Massachusetts, the US.......
$250

PhotoMedex Inc (PHMD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PhotoMedex Inc (PhotoMedex) is a medical device company that provides dermatological solutions. The company offers Neova, Tricomin and IAMIN products. Its products are used in the treatment of skin diseases and conditions such as psoriasis, vitiligo, acne, actinic keratosis. PhotoMedex provides scientific development and has led to a broad range of FDA clearances. The company provides Copper Peptide technology for skin health, hair care and wound care. Its Neova products are used in therapeutic skin care and LED therapy for acne and photodamage. The company caters to dermatologists, professional aestheticians and consumers in the US. PhotoMedex is headquartered in Willow Grove, Pennsylvania, the US. PhotoMedex Inc (PHMD) - Pharmaceuticals & Healthcare - Deals and Alliances Pr......
$250

Enterome Bioscience SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome-based biomarkers and screen for microbiome-derived molecules. It also develops new diagnostic products for patient classification and forecasting treatment response. Enterome provides microbiome-derived molecules as drug candidates. The company develops drugs for treatment of microbiome-related diseases which include metabolic, inflammatory bowel diseases, and central nervous system linked diseases. Enterome is headquartered in Paris, France. Enterome Bioscience SA - Pharmaceuticals & Heal......
$250

ESSA Pharma Inc (EPI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company's lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen receptor, metastatic CRPC, and the androgen receptor as a therapeutic target. The company has collaboration with the Cancer Prevention and Research Institute of Texas (CPRIT). It has office in Houston, Texas, the US. Essa Pharma is headquartered in Vancouver, British Columbia, Canada. ESSA Pharma Inc (EPI) - Pharmaceuticals & Healthcare - Deals and Alliances Prof......
$250

Biomatrica Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Biomatrica Inc (Biomatrica) is a biological stabilization products developer that offers healthcare technology products. The company offers assay design and use; omics sample collection, and transport and storage chemistry products. Its transport and storage chemistry products comprise custom enzyme and reagent preservation systems; purified analyts preservation systems, and sample management products. The company's products are used in portable infectious disease assay treatment, diagnostics, cancer therapy selection, PTSD soldier samples, transport and sequencing of outbreak samples and gen sequencing array applications. It markets its products in Spain, Australia, New Zealand, China, India, Japan, France, Germany, the UK and the US, among others. Biomatrica is headquartered i......
$250

Boehringer Ingelheim GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of C. H. Boehringer Sohn AG & Co KG is a pharmaceutical company, which carries out research, development, manufacture and sale of pharmaceuticals. The company offers a wide range of products including prescription medicines, consumer health care products, animal health care products and biopharmaceuticals. Its products are used in the treatment of central nervous system disorders, respiratory diseases, cardiovascular diseases, metabolic disorders, cancer, urological and viral conditions, among others. The company focuses on the research, development, manufacture and marketing of new drugs of therapeutic value for human and veterinary medicine. Boehringer operates globally through affiliates and is headquartered in Ingelheim am......
$250

MorphoSys AG (MOR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company's pipeline product include MOR208, MOR202, MOR103, MOR209/ES414, MOR106, and MOR107, among others. It drugs are used in the treatment of different types of cancer, psoriasis, rheumatoid arthritis, chronic obstructive pulmonary disease, asthma, solid tumors, eye disease, and other inflammatory diseases. Morphosys offers Human Combinatorial Antibody Library (HuCAL), a recombinant antibody technology which allows generation of therapeutic and diagnostic antibodies. The company provides clinical trials for cancer and inflammatory disorders. It conducts research and development activities with pharmaceutical and biotechnology companies. Morphosys is head......
$250

Micro Labs Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization's business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, amlozaar, angiplat, angizaar, and other products. Micro Labs offers products in various therapeutic areas such as analgesics and anti pyretics, anti-allergics, anti-anginals, anti-arrhythmics, anti-asthmatics and bronchodilators, anti-bacterials and others. The organization concentrates on the development of formulations in various dosage forms including solid dosage, liquid dosage, sterile preparations, injectables, creams and ointments among others. It has operations across Asia, Europe, Latin......
$250

Iconic Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in angiogenesis, inflammation, and metastasis that led to develop new approach to retinal disease and cancer. It provides ICON-1 product that offers novel immune-conjugate fusion protein that works with the body's immune system to address the root causes of acute vision loss in AMD. The company's product is used in treatments in course of infections causing blindness. Iconic Therapeutics is headquartered in South San Francisco, California, the US. Iconic Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analy......
$250